Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2003
12/31/2003CN1464058A Tumor-repressed fusion protein, its encoding gene and use thereof
12/31/2003CN1464057A Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function
12/31/2003CN1464056A Process for the manufacture of cultivatable disease resistant plant somatic cell hybrid
12/31/2003CN1464055A A novel penicillin G acylase and use thereof
12/31/2003CN1464053A New polypeptide-Glycosyl 12 and polynucleotides for coding same
12/31/2003CN1464052A New polypeptide-human RNA uncoiling enzyme 95 and polynucleotides for coding same
12/31/2003CN1464051A Herpesvirus thymine deoxyriboside kinase mutant and use thereof
12/31/2003CN1464049A New polypeptide-human sailer transposase 11 and polynucleotides for coding same
12/31/2003CN1464048A Cobratoxin polypeptide strain obtained from colibacillus and process for obtaining the same
12/31/2003CN1463983A Process for preparing albumin proserum using trans-gene animal
12/31/2003CN1463978A Carcinoma related gene and protein coded thereby
12/31/2003CN1132939C Coding sequence of pyrophosphate synthetase, its encoded polypeptide and its preparing process
12/31/2003CN1132938C Process for producing trans-4-hydroxy-L-proline
12/31/2003CN1132937C Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers
12/31/2003CN1132845C Improved method for obtaining isulin precursor having correctly-bonded cystine bond
12/31/2003CN1132842C Present invention relates to extraction of recombinant proteins produced by prokaryotic microorganism, especially by E. Coli
12/31/2003CA2829581A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
12/31/2003CA2740137A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
12/31/2003CA2530108A1 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof
12/31/2003CA2499709A1 Method for diagnosis of colorectal tumors
12/31/2003CA2493834A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
12/31/2003CA2491803A1 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
12/31/2003CA2491196A1 Materials and methods for inductions of immune tolerance
12/31/2003CA2491038A1 Dna sequence and recombinant production of the grass pollen allergen phl p4
12/31/2003CA2490771A1 Thioesterase-related nucleic acid sequences and methods
12/31/2003CA2490753A1 Methods for developing animal models
12/31/2003CA2490530A1 Methods and compositions for monitoring primer extension and polymorphism detection reactions
12/31/2003CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target
12/31/2003CA2490384A1 Expression vector, host, fused protein, process for producing fused protein and process for producing protein
12/31/2003CA2490197A1 Apparatus for polynucleotide detection and quantitation
12/31/2003CA2490195A1 A non-blended soybean oil with high oleic acid content
12/31/2003CA2490154A1 Method of transforming soybean
12/31/2003CA2490122A1 Antireflective coatings for high-resolution photolithographic synthesis of dna array
12/31/2003CA2490063A1 Methods of modulating cytokinin related processes in a plant using b3 domain proteins
12/31/2003CA2490004A1 Plastid division and related genes and proteins, and methods of use
12/31/2003CA2489930A1 Methods and means to promote gut absorption
12/31/2003CA2489873A1 Ace2 activation for treatment of hypertension, heart, lung and kidney disease
12/31/2003CA2489803A1 Compositions and methods for modulating lymphocyte activity
12/31/2003CA2489617A1 Novel acetylcholinesterase gene responsible for insecticide resistance and applications thereof
12/31/2003CA2489533A1 Plastidial targeting peptide
12/31/2003CA2489348A1 Apo-2 ligand/trail variants and uses thereof
12/31/2003CA2489052A1 Infectious cdna of an approved vaccine strain of measles virus, use for immunogenic compositions
12/31/2003CA2489024A1 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/31/2003CA2488823A1 Method and kit for the diagnosis of ulcerative colitis
12/31/2003CA2486490A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/31/2003CA2485689A1 Compositions and methods for improving plant performance
12/31/2003CA2480892A1 Novel promoter
12/31/2003CA2478508A1 Stable adenoviral vectors and methods for propagation thereof
12/31/2003CA2465519A1 Receptor capture assay
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670528 Transformed with DNA that encodes a protein linked to a promoter which can improve its resistance to dehydration, low temperature and salt; free from dwarfing
12/30/2003US6670527 Gibberellin 2-oxidase
12/30/2003US6670526 Arabidopsis ESD4 gene and method to control flowering time
12/30/2003US6670525 Transgenic plants and cells with altered degree of amylopectin branching
12/30/2003US6670524 Method for predicting fiber length using QTL's and molecular markers
12/30/2003US6670468 2′-substituted nucleosides and oligonucleotide derivatives
12/30/2003US6670467 Nucleotide sequences for tissue-independent or constitutive promoters for genes encoding actin-2, enolase, Gos-2 and L41
12/30/2003US6670466 Human endogenous retrovirus in breast cancer
12/30/2003US6670465 Mutations of the gene may cause a type of X-linked congenital stationary night blindness known as incomplete CSNB, and may also cause Aaland Island Eye Disease
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670462 Nucleotide sequences coding polypeptide for use in the treatment of hepatitis and liver disorders
12/30/2003US6670453 Crosslinking, agglutination, purification
12/30/2003US6670451 Netrins
12/30/2003US6670450 Polypeptide that inhibits the differentiation of myoblasts into myotubes as well as the transactivation function of p53, a transcription factor involved in tumor suppression.
12/30/2003US6670449 Hybrid molecules and their use for optically detecting changes in cellular microenvironments
12/30/2003US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier
12/30/2003US6670342 Method of treating hepatitis delta virus infection
12/30/2003US6670198 Specific binding substances are disposed on a plurality of surfaces provided by substrate and arranged in direction of thickness of substrate
12/30/2003US6670189 Fumonisin detoxification compositions and methods
12/30/2003US6670188 Packaging systems for human recombinant adenovirus to be used in gene therapy
12/30/2003US6670187 Mutant Plk protein and gene encoding the same
12/30/2003US6670186 RNA-loaded antigen presenting cells
12/30/2003US6670185 Compositions and methods for non-targeted activation of endogenous genes
12/30/2003US6670183 88kDa tumorigenic growth factor and antagonists
12/30/2003US6670178 Primary or secondary cell having stably integrated into its genome: exogenous DNA that encodes a glucagon-like peptide 1 related peptide, and DNA sequences that direct expression of the exogenous DNA
12/30/2003US6670177 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus
12/30/2003US6670176 Adeno-associated virus capable of expressing factor IX protein and cells comprising the same
12/30/2003US6670173 Bioreaction module for biochemical reactions
12/30/2003US6670168 Recombinant Streptomyces hygroscopicus host cells that produce 17-desmethylrapamycin
12/30/2003US6670167 Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof
12/30/2003US6670166 Arthropod protein disulfide isomerases
12/30/2003US6670165 Generation preferential hydrolase; obtain sample containing hydrolase, incubate with phosphotransferase, recover hydrolase
12/30/2003US6670164 Isolated human kinase proteins
12/30/2003US6670163 Isolated human kinase proteins
12/30/2003US6670160 Enzymatic polypeptide; for the diagnosis and detection of mammalian tumors
12/30/2003US6670158 Contacting methacrylonitrile in suitable aqueous reaction mixture with catalyst characterized by nitrile hydratase and amidase activity of Comamonas testosteroni 5-MGAM-4D (ATCC 55744), isolating methacrylic acid produced as salt or acid
12/30/2003US6670157 Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use
12/30/2003US6670156 Polynucleotide encoding a diaminopimelate epimerase from Corynebacterium glutamicum
12/30/2003US6670154 Using the vector to fuse a first prokaryote and a second prokaryote with a eukaryotic cell
12/30/2003US6670153 Improved channel and reservoir configurations; for performance of temperature mediated reactions
12/30/2003US6670151 Porcine stem cell factor varients and recombinant cells expressing such polypeptides
12/30/2003US6670150 Isolated human receptor proteins, nucleic acid molecules encoding human receptor proteins, and uses thereof
12/30/2003US6670149 TWIK-5 potassium channel nucleic acids and uses therefor
12/30/2003US6670147 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
12/30/2003US6670143 Polypeptides having lysophosphatidic acid acyltransferase activity and polynucleotides encoding polypeptides having LPAAT activity
12/30/2003US6670140 Determining whether test compound binds to receptor, selecting compound that binds, determining whether compound increases muscle mass or function in skeletal muscle atrophy model system, identifying compound that modulates mass or function
12/30/2003US6670138 Method of diagnosing ischemic stroke via UCP-2 detection
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6670135 Assaying the binding of a DCSema polypeptide to a VESPR protein.
12/30/2003US6670129 Cell transfection apparatus and methods for making and using the cell transfection apparatus
1 ... 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 ... 4023